Carlos Ortíz-Leyba

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*

José Garnacho‐Montero, J.L. García Garmendia, A Barrero-Almodóvar et al. · Critical Care Medicine · 2003 · 725 citations

Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacotherapy +16

Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP

José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez et al. · Clinical Infectious Diseases · 2003 · 472 citations

Life Sciences, Infectious Diseases, Microbiology +15

Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients

José Garnacho‐Montero, Juan Madrazo-Osuna, J.L. García Garmendia et al. · Intensive Care Medicine · 2001 · 403 citations

Medicine, Internal Medicine, Neurology +17

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock

José Garnacho‐Montero, Ana Escoresca‐Ortega, Y. Corcia-Palomo et al. · Intensive Care Medicine · 2013 · 389 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +14

Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

José Garnacho‐Montero, Carlos Ortíz-Leyba, Esteban Fernández-Hinojosa et al. · Intensive Care Medicine · 2005 · 278 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14